Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
6 clinical trials · Condition
◉ Watch Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661) | National Cancer Institute (NCI) | 2021-08-09 |
| Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612) | National Cancer Institute (NCI) | 2019-08-22 |
| Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer (NCT03367741) | National Cancer Institute (NCI) | 2018-04-16 |
Track Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.